| Autor: |
Zimmer AS; Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Steinberg SM; Biostatistics & Data Management Section, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Smart DD; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Burton E; Neuro-Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Houston N; Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Biassou N; Neuro-Radiology, Clinical Center, NIH, Bethesda, MD 20814, USA., Gril B; Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Brastianos PK; Central Nervous System Metastases Program, Massachusetts General Hospital/Harvard Cancer Center Boston, MA 02114, USA., Carter S; Biostatistics and Computation Biology, Dana-Farber Cancer Institute, Boston, MA 02114, USA., Lyden D; Pediatric Hematology Oncology, Weill Cornell Medicine, New York, NY 10065, USA., Lipkowitz S; Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA., Steeg PS; Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20814, USA. |
